Navigation Links
Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
Date:11/19/2008

ket leaders. For more information, visit www.prismventure.com

About Ivy Capital Partners

Ivy Capital Partners, LLC is a specialized private equity investment firm dedicated to investing in promising companies operating in the musculoskeletal sector of the healthcare industry. Ivy Capital Partners invests in early to mid stage healthcare companies with seasoned entrepreneurial management teams, proprietary products, innovative technologies or compelling service opportunities that have the potential for significant investment return. Within the musculoskeletal sector, the company's portfolio includes investments ranging from sports medicine, joint implants, rehabilitation products and services, trauma, spine and life sciences. For more information, please visit www.ivycapitalpartners.com.


'/>"/>
SOURCE Serica Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
2. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
6. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
7. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
8. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
9. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
10. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
11. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical ... and voluntary market withdrawal of one lot of the ... taking this action because some Daytrana patches do not ... release liner removal specification, and as a result, patients ...
(Date:12/2/2009)... COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: ... results of its fourth quarter and fiscal year 2009 on ... Following the release, at 4:45 p.m. ET Martek will ... All interested parties may listen to the call live ...
(Date:12/2/2009)... NEW YORK, Dec. 2 Nearly 600 medical research ... explore novel development approaches and innovative funding strategies at ... ,, FasterCures, the Washington-based center of the ... facilitate multi-sector collaborations needed to turn a scientific discovery ...
(Date:12/2/2009)... Pepscan Holding NV,the Netherlands based biotechnology company focusing on ... announced that it,has appointed Wim E.M. Mol, Ph.D. as ... Dr. Mol will be responsible for all of Pepscans ... the company. He brings to,Pepscan more than 20 years ...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Dutch Biotech Company Pepscan Appoints New CEO 2
... ... First Non-GAAP Profit; Sales Guidance Revised Upward, ... and Cancer, First Quarter 2008 Financial Highlights:, - Soliris(R) (eculizumab) net product sales were $45.5 ... 2007., - Q1 GAAP net loss was $4.2 million, or $0.11 net loss per share, compared ...
... Inc. (Nasdaq: SEPR ), FRAMINGHAM, Mass. ... HTW) today announced that,veteran healthcare executive Timothy J. ... non- executive director, effective immediately., Barberich, 60, ... and chairman of Marlborough, MA-based Sepracor Inc., a ...
... 29 RediClinic LLC announced today,that it is ... Inc.,to provide free diabetes screenings to school age ... identify diabetic and pre-diabetic children and,adolescents. Beginning May ... the,diabetes screenings will be available free of charge ...
Other Biology Technology:Alexion Reports First Quarter 2008 Results 2Alexion Reports First Quarter 2008 Results 3Alexion Reports First Quarter 2008 Results 4Alexion Reports First Quarter 2008 Results 5Alexion Reports First Quarter 2008 Results 6Alexion Reports First Quarter 2008 Results 7Alexion Reports First Quarter 2008 Results 8Alexion Reports First Quarter 2008 Results 9Alexion Reports First Quarter 2008 Results 10Alexion Reports First Quarter 2008 Results 11Alexion Reports First Quarter 2008 Results 12HeartWare Appoints Timothy J. Barberich to Board of Directors 2RediClinic, BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessments to Richmond, Va. School Children 2RediClinic, BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessments to Richmond, Va. School Children 3RediClinic, BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessments to Richmond, Va. School Children 4RediClinic, BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessments to Richmond, Va. School Children 5
(Date:12/3/2009)... CTRC-AACR San Antonio Breast Cancer Symposium continues to attract ... from industry and academia with the goal of eradicating ... scientists and other professionals will gather at the Henry ... 9-13, 2009. The symposium is a partnership between the ...
(Date:12/3/2009)... dwellers must be included in the design of the upcoming ... crisis, according to a scientist at the University of Leeds. ... Lewis argues that at least 50% of the carbon credit ... Emissions from Deforestation and Degredation), should be made to forest ...
(Date:12/2/2009)... an increased risk of developing lung cancer in adulthood, even ... are published in Cancer Epidemiology, Biomarkers & Prevention , ... part of a special tobacco focus in the December issue. ... be diagnosed with lung cancer; more than 159,000 will die ...
Breaking Biology News(10 mins):CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Jupiter Medical Center Announces New High Definition MRI System 6690 1Jupiter Medical Center Announces New High Definition MRI System 6690 2Caltech scientists show how ubiquitin chains are added to cell cycle proteins 62471 1Caltech scientists show how ubiquitin chains are added to cell cycle proteins 62471 2Caltech scientists show how ubiquitin chains are added to cell cycle proteins 62471 3Caltech scientists show how ubiquitin chains are added to cell cycle proteins 62471 4Media alert 3A EUROECHO 2009 62468 1Media alert 3A EUROECHO 2009 62468 2
... National Institutes of Health (NIH) has selected the ... the Genes, Environment and Health Initiative (GEI), a ... , "This is ground-breaking research in understanding the ... said Department of Health and Human Services Secretary ...
... Reader to be the Latest Addition to M2SYS, ... ... Technology, a biometric,technology research and development firm, announced today its ... Plus. The Hamster Plus fingerprint reader features innovative Auto-On,technology ...
... N.Y., Aug. 15 bioMETRX, Inc. (OTC,Bulletin Board: BMRX), ... announced that it is has provided notice to,certain holders ... holders,must surrender said warrants to the company by August ... series B $0.10 warrants that it,has elected to pay ...
Other Biology News:Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 2Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 3Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 4Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 5Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 6Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 7Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 8Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 9M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology 2bioMETRX, Inc. Calls Series B Warrants 2
Mouse monoclonal [CP23] to Ricin communis ( Abpromise for all tested applications)....
Rabbit polyclonal to Testosterone 19 ( Abpromise for all tested applications). Antigen: Testosterone 19 CME HSA (Human)...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Biology Products: